Kemper Corporation <KMPR.N>: UBS cuts target price to $43 from $44
KMPR•Related News
Eikon Therapeutics Appoints Johnny Bennett, Ph.D. To Its Scientific Advisory Board
EIKN•
Vertex Pharma rises after rival genetic disorder drug setback
VRTX•
Socket Mobile Partners With 3Eye Technologies To Expand Industrial Mobility Solutions For Apple-Based Frontline Operations
SCKT•
Verisk weighs appeal after Delaware Chancery Court ruling in AccuLynx case
VRSK•
NASDAQ trade halt continues <SVA.O> reason not available at 10:13 AM
SVA•